Skip to main content
GutCited

Vitamin D для Irritable Bowel Syndrome (IBS)

C

Limited studies suggest vitamin D supplementation may improve IBS symptoms, particularly in deficient individuals. Mechanism via VDR-mediated immune modulation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Итог

Limited studies suggest vitamin D supplementation may improve IBS symptoms, particularly in deficient individuals. Mechanism via VDR-mediated immune modulation.

Key Study Findings

Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None или: None Outcome: IBS symptom improvement with vitamin D supplementation Эффект: None None

Популяция: individuals with irritable bowel syndrome

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None или: Various Outcome: IBS symptom improvement Эффект: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

Популяция: Adult IBS patients

Meta-Analysis Double-blind
The effects of vitamin D intake and status on symptom severity and quality-of-life in adults …
Dose: 3,000 IU daily to 50,000 IU bi-weekly или: Placebo Outcome: IBS symptom severity and quality of life Эффект: MD 20.33 ng/mL [12.91, 27.74] for 25(OH)D; QoL 3.1 None

Популяция: Adults with IBS and deficient/insufficient vitamin D

Review
Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.
Dose: None или: None Outcome: Risk of developing Parkinson's disease Эффект: None None

Популяция: General population (narrative review of PD risk factors)

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None или: None Outcome: Micronutrient deficiency management in pediatric IBD Эффект: None None

Популяция: Children with inflammatory bowel disease (review)

Review
Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology.
Dose: None или: None Outcome: IBS symptom relief and pathophysiology modulation Эффект: None None

Популяция: Patients with irritable bowel syndrome (review)

Key Statistics

3

Исследования

400

Участники

Positive

C

Оценка

Referenced Papers

Scandinavian journal of … 2025
Nutrients 2024 47 цитирований
Journal of gastroenterology … 2023 16 цитирований
World journal of … 2023 9 цитирований
Journal of gastroenterology … 2022 30 цитирований
Journal of gastroenterology … 2022 29 цитирований
Journal of gastroenterology … 2022 4 цитирований
Journal of gastroenterology … 2021 10 цитирований
The journal of … 2020 294 цитирований
Osteoporosis international : … 2020 14 цитирований
Current gastroenterology reports 2017 157 цитирований
PloS one 2017 38 цитирований
World journal of … 2016 238 цитирований
Digestive diseases (Basel, … 2016 41 цитирований
Clinics in dermatology 2016 19 цитирований
World journal of … 2015 62 цитирований
Oman medical journal 2015 56 цитирований
European journal of … 2012 225 цитирований
Inflammatory bowel diseases 2012 224 цитирований
The Cochrane database … 2012 130 цитирований
Current opinion in … 2011 23 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
600-800 IU/day (RDA)
ibdsupport:
1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
deficiencycorrection:
50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance

Верхний предел: 4,000 IU/day (100 mcg); higher doses under medical supervision only

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Positive --
None -- Positive --
3,000 IU daily to 50,000 IU bi-weekly -- Positive --
None -- Mixed --
None -- Neutral --
None -- Positive --
None -- Positive --
None -- Positive 240

Лучшее время приёма: With a meal containing fat for better absorption

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
  • Kidney stones with excessive long-term supplementation
  • Constipation
  • Metallic taste

Известные взаимодействия

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

Допустимый верхний уровень потребления: 4,000 IU/day (100 mcg); higher doses under medical supervision only

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Vitamin D help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is limited but promising evidence that Vitamin D may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is C (Some Evidence).
How much Vitamin D should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.